Stock Price Quote

ZENOTECH LABORATORIES LTD.

NSE : NABSE : 532039ISIN CODE : INE486F01012Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE63.630.5 (+0.79 %)
PREV CLOSE ( ) 63.13
OPEN PRICE ( ) 66.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4932
TODAY'S LOW / HIGH ( )61.60 66.20
52 WK LOW / HIGH ( ) 51107.79
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-06 1989
Management Info
Azadar Hussain Khan - Chairman - Managing Director
Registered Office

Address Survey No. 250-252,Turkapally Villag,Shameerpet Mandal,
Hyderabad,
Telangana-500078

Phone 09032044584 / 585

Email info@zenotech.co.in

Website www.zenotechlab.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE

NEWS

26Apr Zenotech Laboratories informs about in
Pursuant to the Securities and Exchange Board of India Circular dated De..
15Feb Zenotech Laboratories informs about in
Zenotech Laboratories has informed that it enclosed the Integrated Filin..
30Jan Zenotech Laboratories informs about ne
Pursuant to the provisions of Regulation 47 of the Listing Regulations,..
27Dec Zenotech Laboratories informs about cl
Pursuant to the Company’s Code of Conduct for Prohibition of Insider Tra..
23Oct Zenotech Laboratories informs about ou
In connection with the Board Meeting intimation dated October 17, 2024,..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit12.2956.13
Gross Profit 31.86 106.92
Operating Profit 49.62157.29
Net Sales 121.31430.47

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Glaxosmithkline Phar (BSE)
peergroup  2984.45 (7.07%)
M.Cap ( in Cr)50770.99
Caplin Point Lab (BSE)
peergroup  2250.95 (5.75%)
M.Cap ( in Cr)16973.41
Alkem Laboratories (BSE)
peergroup  5379.00 (2.25%)
M.Cap ( in Cr)64290.10
Divi's Lab (BSE)
peergroup  6558.00 (1.66%)
M.Cap ( in Cr)174146.06
Astrazeneca Pharma I (BSE)
peergroup  7999.50 (0.99%)
M.Cap ( in Cr)20067.88

Shareholding Pattern

PROMOTERS 68.84%
NON-INSTITUTION 30.17%
GOVERNMENT 0.98%
FI/BANKS/INSURANCE 0.01%
MUTUAL FUNDS/UTI 0%
FII 0%

About Zenotech Laboratories Ltd.

Zenotech Laboratories Ltd. was incorporated in the year 1989. Its today's share price is 63.63. Its current market capitalisation stands at Rs 390.17 Cr. In the latest quarter, company has reported Gross Sales of Rs. 408.33 Cr and Total Income of Rs.418.37 Cr. The company's management includes Premal Hemant Gandhi, Chintan Jitendra Shah, Rakeshchandra Jagdishprasad Sinha, Jagruti Prashant Sheth, Jignesh Anantray Goradia, Azadar Hussain Khan, Abdul Gafoor Mohammad.

It is listed on the BSE with a BSE Code of 532039 , NSE with an NSE Symbol of and ISIN of INE486F01012. It's Registered office is at Survey No. 250-252,Turkapally Villag,Shameerpet MandalHyderabad-500078, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates, BSR & Associates LLP, PKF Sridhar & Santhanam LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.